Xiaozeng Lin

1.0k total citations
34 papers, 731 citations indexed

About

Xiaozeng Lin is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Xiaozeng Lin has authored 34 papers receiving a total of 731 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 14 papers in Pulmonary and Respiratory Medicine and 11 papers in Cancer Research. Recurrent topics in Xiaozeng Lin's work include Prostate Cancer Treatment and Research (11 papers), Cancer, Lipids, and Metabolism (6 papers) and DNA Repair Mechanisms (5 papers). Xiaozeng Lin is often cited by papers focused on Prostate Cancer Treatment and Research (11 papers), Cancer, Lipids, and Metabolism (6 papers) and DNA Repair Mechanisms (5 papers). Xiaozeng Lin collaborates with scholars based in Canada, China and United States. Xiaozeng Lin's co-authors include Damu Tang, Yan Gu, Anil Kapoor, Diane Ojo, Pierre Major, Nicholas Wong, Fengxiang Wei, Wenjuan Mei, Judy Yan and Jingyi Peng and has published in prestigious journals such as Cancer Research, International Journal of Molecular Sciences and Cancer Letters.

In The Last Decade

Xiaozeng Lin

33 papers receiving 727 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaozeng Lin Canada 17 465 239 236 223 61 34 731
Michael M. Lizardo United States 14 349 0.8× 196 0.8× 247 1.0× 222 1.0× 63 1.0× 24 746
Julia Hoefer Austria 14 416 0.9× 333 1.4× 268 1.1× 272 1.2× 94 1.5× 18 828
Raymond J. Louie United States 10 551 1.2× 138 0.6× 157 0.7× 342 1.5× 93 1.5× 22 791
Özge Saatci United States 18 461 1.0× 107 0.4× 230 1.0× 295 1.3× 60 1.0× 29 749
Diane Ojo Canada 12 480 1.0× 143 0.6× 157 0.7× 321 1.4× 41 0.7× 15 647
Rokaya El Ansari United Kingdom 18 629 1.4× 134 0.6× 212 0.9× 475 2.1× 37 0.6× 24 891
Lakshmi Reddy Bollu United States 15 565 1.2× 154 0.6× 233 1.0× 319 1.4× 44 0.7× 24 930
Bethany C. Prudner United States 12 263 0.6× 190 0.8× 168 0.7× 214 1.0× 58 1.0× 19 586
Phuong Nguyen United States 7 532 1.1× 129 0.5× 159 0.7× 354 1.6× 34 0.6× 10 728
Madeleine L. Craze United Kingdom 18 638 1.4× 127 0.5× 204 0.9× 451 2.0× 33 0.5× 22 892

Countries citing papers authored by Xiaozeng Lin

Since Specialization
Citations

This map shows the geographic impact of Xiaozeng Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaozeng Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaozeng Lin more than expected).

Fields of papers citing papers by Xiaozeng Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaozeng Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaozeng Lin. The network helps show where Xiaozeng Lin may publish in the future.

Co-authorship network of co-authors of Xiaozeng Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaozeng Lin. A scholar is included among the top collaborators of Xiaozeng Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaozeng Lin. Xiaozeng Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gu, Yan, Lizhi He, Anil Kapoor, et al.. (2023). HSD17B6 delays type 2 diabetes development via inhibiting SREBP activation. Metabolism. 145. 155631–155631. 1 indexed citations
2.
Gu, Yan, Xiaozeng Lin, Ying Dong, et al.. (2023). PCSK9 facilitates melanoma pathogenesis via a network regulating tumor immunity. Journal of Experimental & Clinical Cancer Research. 42(1). 2–2. 25 indexed citations
3.
Lin, Xiaozeng, Ying Dong, Yan Gu, et al.. (2023). Taxifolin Inhibits the Growth of Non-Small-Cell Lung Cancer via Downregulating Genes Displaying Novel and Robust Associations with Immune Evasion Factors. Cancers. 15(19). 4818–4818. 2 indexed citations
4.
Mei, Wenjuan, Ying Dong, Yan Gu, et al.. (2023). IQGAP3 is relevant to prostate cancer: A detailed presentation of potential pathomechanisms. Journal of Advanced Research. 54. 195–210. 5 indexed citations
5.
Dong, Ying, Xiaozeng Lin, Anil Kapoor, et al.. (2021). Insights of RKIP-Derived Suppression of Prostate Cancer. Cancers. 13(24). 6388–6388. 8 indexed citations
6.
Gu, Yan, Lizhi He, Xiaozeng Lin, et al.. (2021). Prognostic and Therapeutic Potential of the OIP5 Network in Papillary Renal Cell Carcinoma. Cancers. 13(17). 4483–4483. 5 indexed citations
8.
Gu, Yan, et al.. (2020). The Oncogenic Potential of the Centromeric Border Protein FAM84B of the 8q24.21 Gene Desert. Genes. 11(3). 312–312. 13 indexed citations
9.
Lin, Xiaozeng, Anil Kapoor, Yan Gu, et al.. (2020). Construction of a Novel Multigene Panel Potently Predicting Poor Prognosis in Patients with Clear Cell Renal Cell Carcinoma. Cancers. 12(11). 3471–3471. 10 indexed citations
11.
Ojo, Diane, et al.. (2018). Polycomb complex protein BMI1 confers resistance to tamoxifen in estrogen receptor positive breast cancer. Cancer Letters. 426. 4–13. 22 indexed citations
12.
Jiang, Yanzhi, Wenjuan Mei, Yan Gu, et al.. (2018). Construction of a set of novel and robust gene expression signatures predicting prostate cancer recurrence. Molecular Oncology. 12(9). 1559–1578. 22 indexed citations
13.
Lin, Xiaozeng, Yan Gu, Anil Kapoor, et al.. (2017). Overexpression of MUC1 and Genomic Alterations in Its Network Associate with Prostate Cancer Progression. Neoplasia. 19(11). 857–867. 23 indexed citations
14.
Yan, Judy, Diane Ojo, Anil Kapoor, et al.. (2016). Neural Cell Adhesion Protein CNTN1 Promotes the Metastatic Progression of Prostate Cancer. Cancer Research. 76(6). 1603–1614. 40 indexed citations
15.
Xie, Yanyun, Anil Kapoor, Diane Ojo, et al.. (2016). Dataset on the effects of CYB5D2 on the distribution of HeLa cervical cancer cell cycle. Data in Brief. 6. 811–816. 5 indexed citations
16.
Ojo, Diane, Yun Liu, Enli Wang, et al.. (2015). Factors Promoting Tamoxifen Resistance in Breast Cancer via Stimulating Breast Cancer Stem Cell Expansion. Current Medicinal Chemistry. 22(19). 2360–2374. 56 indexed citations
17.
Lin, Xiaozeng, Yan Gu, & Damu Tang. (2015). BMI1, ATM and DDR. Oncoscience. 2(8). 665–666. 7 indexed citations
18.
Xie, Yanyun, Anil Kapoor, Diane Ojo, et al.. (2015). CYB5D2 displays tumor suppression activities towards cervical cancer. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1862(4). 556–565. 12 indexed citations
19.
Melo, Jason De, Xiaozeng Lin, Lizhi He, et al.. (2014). SIPL1-facilitated PTEN ubiquitination contributes to its association with PTEN. Cellular Signalling. 26(12). 2749–2756. 17 indexed citations
20.
Wei, Fengxiang, Judy Yan, Damu Tang, et al.. (2012). Inhibition of ERK activation enhances the repair of double-stranded breaks via non-homologous end joining by increasing DNA-PKcs activation. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1833(1). 90–100. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026